Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues
Authors:
Open Access
- 29 July 2017
- journal article
- Published by Wiley in Thoracic Cancer
- Vol. 8 (5) , 495-500
Abstract
Background: This study was conducted to investigate the exchange protein directly activated by cAMP (Epac1), PDE4, and PKC expression in breast cancer tissues, and the correlation between these proteins and AKAP95, Cx43, cyclin D2, and cyclin E1.Methods: PV‐9000 two‐step immunohistochemistry was used to analyze protein expression.Results: The positive rate of Epac1 protein expression in breast cancer tissues (58%) was higher than in para‐carcinoma tissues (10%) (P < 0.05). There were no significant differences in the positive rates of PDE4 and PKC expression between breast cancer and para‐carcinoma tissues (P > 0.05). The positive expression rate of PDE4 was higher in the P53 protein positive group compared to the P53 negative group (P < 0.05). Correlations between Epac1 and cyclin D2, PDE4 and cyclin D2, AKAP95 and PKC, Cx43 and PKC, and cyclin D2 and PKC proteins were observed (P < 0.05).Conclusion: Epac1 expression in breast cancer tissues was increased, suggesting that the protein may be involved in the development of breast cancer. Correlations between Epac1 and cyclin D2, PDE4 and cyclin D2, AKAP95 and PKC, Cx43 and PKC, and cyclin D2 and PKC proteins suggested synergistic effects among these proteins in the development of breast cancer.Keywords
Funding Information
- Shandong Province (2015GSF118148)
This publication has 20 references indexed in Scilit:
- Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivoMedical Oncology, 2016
- cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseasesExpert Opinion on Therapeutic Patents, 2014
- Integrated Analysis of Transcriptomes of Cancer Cell Lines and Patient Samples Reveals STK11/LKB1–Driven Regulation of cAMP Phosphodiesterase-4DMolecular Cancer Therapeutics, 2014
- MicroRNA-433 Inhibits Liver Cancer Cell Migration by Repressing the Protein Expression and Function of cAMP Response Element-binding ProteinJournal of Biological Chemistry, 2013
- Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cellsMolecular Carcinogenesis, 2013
- Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancersProceedings of the National Academy of Sciences, 2013
- A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and InvasionMolecular Pharmacology, 2013
- Rap1 GTPases: An emerging role in the cardiovasculatureLife Sciences, 2011
- RETRACTED: Epac1‐induced cellular proliferation in prostate cancer cells is mediated by B‐Raf/ERK and mTOR signaling cascadesJournal of Cellular Biochemistry, 2009
- G1/S Cyclins Interact with Regulatory Subunit of PKA via A-Kinase Anchoring Protein, AKAP95Cell Cycle, 2006